Nebivolol Dosing When Switching from Atenolol 100mg
Start nebivolol at 5 mg once daily when transitioning from atenolol 100 mg, as this is the standard recommended starting dose for hypertension and provides equivalent blood pressure control with superior tolerability. 1
Rationale for 5 mg Starting Dose
The FDA-approved starting dose for nebivolol in hypertension is 5 mg once daily, which can be titrated up to 40 mg if needed for additional blood pressure reduction 1. Multiple comparative studies demonstrate that nebivolol 5 mg once daily produces equivalent antihypertensive efficacy to atenolol 100 mg once daily 2, 3.
Key Evidence Supporting This Dose Equivalence:
Blood pressure reduction: Nebivolol 5 mg and atenolol 100 mg produce similar reductions in both systolic and diastolic blood pressure (approximately -19/-15 mmHg vs -18/-15 mmHg respectively) 2
Response rates: Both doses show comparable distribution of responders and non-responders 2
Anti-ischemic effects: At steady-state, nebivolol 5 mg and atenolol 100 mg demonstrate approximately equal anti-ischemic activity when measured at peak effect 3
Important Advantages of Nebivolol at This Dose
Nebivolol 5 mg offers several clinical benefits over atenolol 100 mg despite equivalent blood pressure control:
- Superior tolerability: Significantly lower incidence of adverse effects (12.8% vs 36.8%) 4
- Better exercise capacity: Unlike atenolol, nebivolol does not decrease maximal or endurance exercise capacity 5
- Less bradycardia: Produces less heart rate reduction than atenolol, which may improve tolerability 2
- Improved vascular function: Better effects on arterial elasticity and endothelial function due to nitric oxide-mediated vasodilation 6, 7
- Cardiovascular outcomes: Associated with 17-24% reduction in incident cardiovascular events compared to nonvasodilatory beta-blockers like atenolol 8
Practical Switching Algorithm
- Discontinue atenolol 100 mg (no tapering required for switching between beta-blockers in stable patients)
- Start nebivolol 5 mg once daily the following day
- Reassess blood pressure at 2 weeks - if inadequate control, increase to 10 mg
- Maximum dose: Can titrate up to 40 mg once daily at 2-week intervals if needed 1
Special Considerations
Dose adjustments are needed only for:
- Severe renal impairment (CrCl <30 mL/min): Start at 2.5 mg daily 1
- Moderate hepatic impairment: Start at 2.5 mg daily 1
- Elderly patients: No dose adjustment required 1
Guideline Context
Both the 2024 ESC and 2017 ACC/AHA guidelines recommend vasodilating beta-blockers (including nebivolol) as preferred agents when beta-blockade is chosen for hypertension without compelling indications 9, 10. Nebivolol's vasodilating properties through nitric oxide release distinguish it from traditional beta-blockers like atenolol 9.